CymaBay Therapeutics (CBAY) Misses Q2 EPS by 2c

CymaBay Therapeutics (NASDAQ: CBAY) reported Q2 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on CymaBay Therapeutics (CBAY) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c